Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quanterix Corp
(NQ:
QTRX
)
16.49
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quanterix Corp
< Previous
1
2
3
Next >
Quanterix To Report First Quarter 2024 Financial Results
April 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
March 21, 2024
From
Quanterix
Via
Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
March 04, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
March 01, 2024
Via
Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 9/1
September 01, 2023
Via
Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/21
August 21, 2023
Via
Investor Brand Network
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
February 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/16
August 16, 2023
Via
Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/8
August 08, 2023
Via
Investor Brand Network
Quanterix to Present at Cowen’s 44th Annual Health Care Conference
February 23, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
February 16, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 12, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 13, 2023
From
Quanterix Corporation
Via
Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
November 13, 2023
From
Sotera Health Services, LLC
Via
GlobeNewswire
Quanterix Releases Operating Results for Third Quarter 2023
November 06, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 30, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
October 24, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection
October 23, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease Day
September 28, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Quanterix Corporation
Via
Business Wire
William P. Donnelly Appointed to Quanterix’s Board of Directors
August 21, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Vandana Sriram as Chief Financial Officer
August 09, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for Second Quarter 2023
August 07, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
August 03, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
July 31, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
July 06, 2023
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
June 07, 2023
From
Quanterix Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.